Stockreport

Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Update

Brickell Biotech, Inc.  (BBI) 
PDF Completed sale of sofpironium bromide to Botanix Pharmaceuticals for up to $9 million in upfront and potential near-term regulatory milestone payments, $168 million in p [Read more]